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CCR = chemokine receptor; ICAM = intercellular adhesion molecule; MIP = macrophage inflammatory protein; NF-kB = nuclear factor-kB; PCR =
polymerase chain reaction; pfu = plaque-forming units; PVM = pneumonia virus of mice; RANTES = regulated upon activation, normal T-cell
expressed and secreted; RSV = respiratory syncytial virus; TNF = tumor necrosis factor.
Available online http://respiratory-research.com/content/2/4/225
Introduction
RSV and PVM are viruses of the family Paramyxoviridae,
subfamily pneumovirus; they are enveloped, single-
stranded, nonsegmented RNA viruses that can cause
intense viral bronchiolitis in humans and mice, respec-
tively. In its most severe form, the lower respiratory tract
infection caused by pneumoviruses is associated with the
development of peribronchiolar infiltrates that are accom-
panied by submucosal edema and bronchorrhea, and ulti-
mately leads to bronchiolar obstruction and compromised
oxygen transfer. As the infection is confined to the respira-
tory epithelium, the responses of these cells are clearly of
primary importance in determining the nature and extent of
the resulting inflammatory process.
Most of our understanding of responses to pneumovirus
infection has emerged from studies of RSV infection of
human epithelial target cells in vitro; a list of genes and/or
gene products produced by epithelial cells in response to
RSV infection in vitro is provided in Table 1. At the cellular
level, epithelial cells initially respond to RSV infection by
reducing their ciliary beat frequency. Production and
release of chemoattractant cytokines (chemokines) can be
observed as early as 12 h after infection, leading to the
recruitment of specific leukocyte subsets to the lung
tissue. RSV-infected epithelial cells become resistant to
tumor necrosis factor (TNF)-a-induced apoptosis, but later
fuse to form giant-cell syncytia and die by cellular necro-
sis. We review the molecular bases (to the extent that they
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are understood) of these specific responses, and discuss
several novel strategies that may permit us to study the
responses to RSV and PVM infection in a more coherent
and systematic manner.
Ciliostasis
Tristram  et al [1] observed that explanted respiratory
epithelial cells slow their ciliary beat frequency almost
immediately after exposure to RSV, with complete ciliosta-
sis seen as early as 6 h after the initial infection. The mole-
cular basis of ciliostasis remains completely unknown.
Production and release of chemokines
The chemokines and cytokines with production and
release that has been associated with RSV infection of
human epithelial cells are listed in Table 1. Much of this
work was also recently reviewed elsewhere [2,3]. We
focus here on the three chemokines whose molecular
mechanisms and physiologic implications are best
understood.
Interleukin-8
The earliest reports on this subject described production
of the neutrophil chemoattractant IL-8 from tissue culture
supernatants from RSV-infected cells [4–6] and in nasal
secretions from patients with viral rhinitis [7]. IL-8 has
since been detected in lower airway secretions from
patients with severe RSV bronchiolitis [8], and the neu-
trophil influx observed in response to this infection is prob-
ably due, at least in part, to the activity of this chemokine.
At the cellular level IL-8 production can be observed in
response to inactivated RSV virions, whereas IL-8 produc-
tion in response to active infection was inhibited by rib-
avarin, amiloride, and antioxidants [9,10]. Several groups
have demonstrated activation of the transcription factor
nuclear factor-kB (NF-kB) in response to RSV infection,
and NF-kB is recognized for its central role in eliciting the
production of IL-8 [9,11,12]. The transcription factor
NF-IL-6 is also produced in response to RSV infection
[13], and participates in a co-operative manner with NF-kB
in the regulation of IL-8 gene expression [11], although
later studies suggest that activator protein-1 may function
preferentially in this role [14]. Interestingly, the NF-kB regu-
lator IkBa, which functions by inhibiting NF-kB activation in
response to TNF-a, was produced with different kinetics
and does not promote a reversal of NF-kB activation in
response to RSV infection as it does in response to TNF-a
[15]. Most recently, Casola et al [16] demonstrated that
the IL-8 promoter contains independent response
elements, with nucleotides –162 to –132 representing a
unique RSV response element that is distinct from
elements necessary for IL-8 production in response to
TNF-a. This concept of a stimulus-specific response will
probably make an important contribution toward our under-
standing of how pneumoviruses promote transcription of
unique and specific sets of independent gene products.
Regulated upon activation, normal T-cell expressed and
secreted
The pleiotropic chemokine regulated upon activation,
normal T-cell expressed and secreted (RANTES) has also
been detected in supernatants from RSV-infected epithe-
lial cells in culture [17,18], as well as in upper and lower
airway secretions from patients infected with this virus
[7,8]. RANTES acts as a chemoattractant for eosinophils
and monocytes in vitro, although its role in vivo is some-
what less clear. Similar to IL-8, RANTES can be produced
in vitro in response to inactivated virions [8], and involves
NF-kB activation, binding, and nuclear translocation [19].
However, Koga et al [20] demonstrated that stabilization
of RANTES mRNA, a response to RSV infection mediated
in part by nucleotides 11–389 of the RANTES gene, is
probably the primary mechanism underlying increased pro-
duction and secretion of RANTES protein. Further studies
will determine whether a similar mechanism is also in
place for IL-8 and other RSV-mediated responses.
Table 1
Alterations in gene expression in response to RSV infection
Group Examples
Cell-surface ICAM-1  (CD54)
molecules CD18
Vascular cell adhesion molecule (VCAM)
Major histocompatibility complex (MHC) I and II
CD14
CD15
Fas
Muscarinic receptors
b2-adrenergic receptors
Lewisx antigen
Chemokines and  IL-8
cytokines IL-11
IL-6
Soluble TNF receptor
RANTES
Monocyte chemoattractant protein (MCP)-1
MIP-1a
Granulocyte–macrophage colony-stimulating 
factor (GM-CSF)
IL-1b
IFN-b
Interleukin-1a
Transcription NF-kB
factors NF-IL-6
Others Inducible nitric oxide synthase (iNOS)
Vascular endothelial growth factor (VEGF)/VPF
Endothelin-1
5-Lipoxygenase
Leukotrienes
IEX-1L
Cytokeratin-17
Increased expression of the these genes and/or gene products has
been observed in response to RSV infection of target cells in vitro.
VPF, vascular permeability factor.c
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Macrophage inflammatory protein-1a a
Several groups have recently shown that macrophage
inflammatory protein (MIP)-1a is released from RSV-
infected cells in culture [7,21]; MIP-1a was also
detected in upper and lower airway secretions from
RSV-infected patients [7,8]. Interestingly, of the three
aforementioned chemokines, MIP-1a is the one that is
most closely correlated with the presence of eosinophil
degranulation products; this, together with data from our
PVM model of pneumovirus infection [22], has sug-
gested to us that MIP-1a plays a pivotal role in
eosinophil recruitment in response to primary pneu-
movirus infection. Interestingly, production of MIP-1a in
cell culture requires active viral replication [8], which
suggests that this response may proceed by a mecha-
nism that is completely distinct from that which elicits
production of RANTES and IL-8. However, no reports to
date have addressed the molecular mechanism that
underlies the RSV-mediated MIP-1a response.
Cell-surface adhesion molecules
A list of cell-surface molecules that have been reported as
expressed in response to RSV infection is shown in
Table 1. We focus here on the expression of intercellular
adhesion molecule (ICAM)-1 (CD54) and the leukocyte
integrin CD18.
Intercellular adhesion molecule-1
Increased expression of this cell-surface adhesion protein
was observed in both respiratory epithelial cell lines
[23,24] and in human nasal epithelial cells [25] in
response to infection with RSV in vitro. Chini et al [26]
demonstrated that the expression of ICAM-1 mRNA,
similar to IL-8 and RANTES, was dependent on an intact
NF-kB site in the gene promoter, and demonstrated a
role for the consensus binding site for the factor CCAAT/
enhancer-binding protein. Stark et al [27] demonstrated
that ICAM-1 and CD18 expressed in response to RSV
serve to enhance neutrophil and eosinophil binding to
epithelial cells.
CD18
CD18 is a polypeptide of the integrin family that func-
tions in mediating cell–cell interactions. Several groups
have observed expression of CD18 on epithelial cells in
response to RSV infection [27,28], with CD18 shown to
enhance the degranulation of eosinophils in this specific
setting [28]. Of particular interest are the recent find-
ings relating expression of CD18 (along with CD14) to
earlier literature on bacterial superinfections in the
setting of viral infections. Earlier studies [29,30]
reported enhanced binding of bacteria to respiratory
epithelial cells that were infected with RSV, findings that
had clinical implications relating to acute bacterial otitis
media in infants.
Two more recent studies addressed the question of
binding sites. Saadi et al [31] determined that two strains
of the pathogen Bordetella pertussis bound more effi-
ciently to RSV-infected cells, and that the binding was
reduced upon pretreatment of the cells with anti-CD14 or
anti-CD18 antibodies. Similarly, Raza et al [32] reported
that both CD14 and CD18 on RSV-infected epithelial cells
contributed to the binding of nonpilate Neisseria meningi-
tidis. In vivo testing is required before the clinical signifi-
cance of these intriguing findings can be appreciated.
Protection from programmed cell death
RSV-infected epithelial cells in culture do not show features
that are suggestive of apoptosis (ie no evidence of mem-
brane blebbing, fragmentation of chromosomal DNA, or
characteristic changes in nuclear morphology). Takeuchi et
al [33] showed that, although RSV-infected epithelial cells
express a number of apoptosis-associated genes, including
interferon regulatory factor-1, IL-1b-converting enzyme and
caspase 3, they do not undergo formal apoptosis.
As part of our attempts to understand mucosal responses
in a more systematic manner (see below), we discovered
that RSV-infected epithelial cells express the recently
described antiapoptosis gene IEX-1L [34]. In our studies,
we found that expression of IEX-1L is a response to active
virus; no gene expression was observed in response to
irradiated, replication-incompetent virus. Moreover, expres-
sion of IEX-1L is not observed in response to adenoviral
infection, suggesting that expression of this gene is not a
universal response to cellular perturbation, or indeed to all
viral infections. Functionally, we also demonstrated that
RSV infection protects epithelial cells from TNF-a-induced
apoptosis, an effect that is temporally associated with the
expression of IEX-1L.
Apoptosis is generally considered to be a highly efficient
self-defense mechanism employed by host target cells,
because it permits the infected host to dispose of viral
proteins and nucleic acids on a single-cell basis without
inducing an inflammatory response. It is thus not surpris-
ing that many viruses have evolved strategies to circum-
vent this response. Of interest, Krilov et al [35]
demonstrated that monocytes and cord blood mononu-
clear cells are similarly protected from apoptosis when
infected with RSV.
Although virus-induced protection from apoptosis appears
advantageous to the virus alone, another interpretation may
be considered. Because respiratory epithelial cells are now
recognized as a major source of leukocyte chemoattrac-
tants, and because leukocyte recruitment to the lung has
been associated with enhanced viral clearance and pro-
longed survival in pneumovirus infection [22], the ability to
maintain chemoattractant production from viable cells may
ultimately benefit the host organism as well.
Available online http://respiratory-research.com/content/2/4/225Syncytia formation
In tissue culture, RSV-infection is characterized by the for-
mation of giant-cell syncytia. The mechanisms for the for-
mation of these fused masses of cells depend in part on
the expression of the RSV-specific fusion (F) protein on
the surface of infected host cells, and in part on virus-
mediated changes in cytoskeletal architecture. It is impor-
tant to note that RSV-induced changes in cytoskeletal
architecture are not restricted to cell lines grown in vitro,
as giant-cell syncytia have also been found in pathologic
lung specimens obtained from both humans and animals
that were infected with RSV.
Again, as part of our systematic study of gene expression
in response to pneumovirus infection, we found that
human respiratory epithelial cells respond to RSV infec-
tion with increased expression of the cytoskeletal protein
cytokeratin-17 [36]. Cytokeratin-17 is a 46-kDa
cytoskeletal protein that belongs to the class I acidic
cytokeratin family. In the lung, expression of cytokeratin-
17 is normally restricted to basal epithelial cells of the
larynx, trachea, and bronchi. In RSV-infected cells, we
found expression of Ck-17 predominantly at sites of syn-
cytia formation, and thus provided the first description of
a unique component of these pathognomonic structures
at the molecular level. Similar to what has been reported
for the production of IL-8, expression of Ck-17 is depen-
dent on the activity of the transcription factor NF-kB, and
future studies will determine the role of the NF-kB con-
sensus site (–200 to –208 of the cytokeratin-17 pro-
moter) in mediating this response.
A novel model of inflammatory viral
bronchiolitis: pneumonia virus of mice
To date, efforts to study pneumovirus-induced alterations
in gene expression have relied heavily on in vitro models of
virus-infected cells and cell lines. The intrinsic value of
characterizing the genes identified in this artificial system
is by definition limited, and the clinical and physiologic sig-
nificance of any findings must ultimately be tested in vivo.
To some extent, the study of gene products in clinical
specimens is possible, but this approach is limited, cum-
bersome, and dictated by sample availability. It is clear that
an appropriate animal model of inflammatory bronchiolitis
is required to characterize the alterations in gene expres-
sion discovered using the available in vitro models.
Although RSV has been used for the study of specific
allergic reactions to viral antigens, it is not a natural
pathogen of mice, and intranasal inoculation of virus at
high titer results in, at best, a minimal primary infection
with a correspondingly minimal inflammatory response. In
order to study gene expression in response to primary
pneumovirus infection in vivo, we developed a novel
mouse model of inflammatory bronchiolitis using the
natural rodent pneumovirus pathogen and closest phylo-
genetic relative of RSV [37] – PVM. We presented our
initial findings on PVM infection in mice in three recent
publications [22,38,39]. A summary of these findings is
presented in Table 2 and Fig. 1.
To begin, we described the cellular and biochemical
pathology observed in response to PVM infection in mice
[38]. We found that infection could be established with as
few as 30 plaque-forming units (pfu) of PVM in the inocu-
lum, with infection resulting in significant morbidity and
mortality, and viral recoveries in the order of 108 pfu/g
lung tissue. We also noted inflammatory bronchiolitis as
among the immediate responses to this infection, with
bronchoalveolar lavage fluid containing virtually 100%
neutrophils and eosinophils obtained as early as 3 days
after inoculation. Furthermore, we found that infection was
accompanied by the production of the proinflammatory
chemokine MIP-1a, which was previously shown by Cook
et al [40] to be an important component of the inflamma-
tory response to the orthomyxovirus influenza virus.
We also described the role played by MIP-1a in the
pathogenesis of PVM-induced bronchiolitis [22]. Specifi-
Respiratory Research    Vol 2 No 4 Domachowske et al
Table 2
Features of RSV infection of humans, RSV in mice, and PVM infection in mice: a comparison
Features Humans infected with RSV Mice infected with PVM Mice infected with RSV
Inoculum required Very low (presumed) <30 pfu >0.5–2 million pfu
Pulmonary inflammation Granulocytic bronchiolitis Granulocytic bronchiolitis Mild mononuclear cell infiltrate
Eosinophil recruitment Yes Yes (8–12%); see arrows in panel D, Fig. 1 No
Progression to ARDS Yes Yes No
Percent with respiratory failure 10% 60% (low dose); 100% (high dose) 0%
Weight loss Not reported, but likely 30% 12–15%
Peak lung viral titers 106 pfu/ml nasal secretion 106–108 pfu/g lung Less than inoculum
ARDS, acute respiratory distress syndrome.cally, we explored the responses of gene-deleted mice to
infection with PVM, and found no inflammatory response
in mice deficient in MIP-1a expression (MIP-1a–/–) and
only minimal virus-induced inflammation in mice that
lacked the major MIP-1a receptor on granulocytes
chemokine receptor (CCR)1 (CCR1–/–). Although the
inflammatory response is often considered to be unnec-
essary and indeed detrimental, we demonstrated that the
absence of granulocytic inflammation was associated
with enhanced recovery of infectious virions, as well as
with accelerated mortality. These results suggest that
the MIP-1a/CCR1-mediated acute inflammatory
response protects mice by delaying the lethal sequelae
of viral infection.
Our most recent report on this subject [39] presents a
direct comparison between the responses of mice to chal-
lenge with PVM and RSV. Although RSV is not a natural
pathogen of mice, it has been used extensively in mouse
models of human infection because a limited, or ‘semiper-
missive’ infection can be established via intranasal inocula-
tion of virus at very high titers. In this regard, we found (as
have others) that RSV infection did not result in any mea-
surable degree of morbidity, and that viral recovery was
significantly lower than that found in the inoculum; these
results suggested that there was no significant viral repli-
cation in mouse lung tissue. We further demonstrated that
the inflammatory response to RSV challenge was minimal,
as few leukocytes were recruited to the lungs (Fig. 1).
Taken together, our results suggest that infection of mice
with PVM provides a superior model for the study of acute
inflammatory bronchiolitis in response to pneumovirus
infection  in vivo. The advantages of this model include the
following: clinical parameters – morbidity and mortality –
that can be measured clearly and specifically; clear evi-
dence of viral replication in lung tissue, with incremental
recoveries that, at peak, are in excess of 108 pfu/g in
response to as few as 30 pfu in the inoculum; and a dra-
matic granulocytic response that is modulated at least in
part by the proinflammatory chemokine MIP-1a and its
receptor CCR1.
Available online http://respiratory-research.com/content/2/4/225
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Figure 1
Pulmonary histopathology during pneumovirus infection. Lungs from mice infected with PVM (60 pfu) for (A, D) 3 days, (B, E) 5 days, and (C, F) 7
days. Images at lower magnification (A, B, and C ×400) show the extent of inflammatory changes, whereas the higher power images (D, E, and F
×1000) demonstrate that the cells are predominantly granulocytes. The arrows in panel D highlight the presence of eosinophils. Lung histology
from animals infected with RSV (1 million pfu) for (G) 3, (H) 5, and (I) 7 days (×400). Note the paucity of acute inflammatory changes.Genomic approaches to alterations in gene
expression
Traditionally, analysis of gene expression through mea-
surement of steady-state levels of individual mRNAs could
be conducted only one gene at a time using northern blot-
ting, dot blots, or quantitative reverse transcription-PCR.
Differential display, serial analysis of gene expression, and
total gene analysis offer great promise, because they are
multiplex technologies that provide simultaneous analysis
of multiple mRNAs isolated under conditions of interest via
PCR amplification techniques. DNA hybridization arrays
are theoretically the most efficient of the gene expression
analysis techniques. Although many skeptics have
described these genome-based approaches as expensive,
nonhypothesis-driven ‘fishing expeditions’, we view them
as broad-based screening techniques that will enable us
to identify patterns of gene expression that can then be
subjected to careful characterization and analysis.
Differential display
Differential display is a semiquantitative, reverse transcrip-
tion-PCR-based technique that is used to compare
mRNAs from two or more conditions of interest. Both
increased and decreased expression of specific ampli-
cons will be evident – an obvious advantage to this
approach. Total RNA can be isolated from virus infected
versus uninfected cells or mouse lungs both before and
during infection, and differential display is performed using
degenerate T11(XY) anchoring primers and random
upstream oligomers, as described elsewhere [34,36]. The
resulting PCR products are separated by electrophoresis,
and the gel is dried and exposed to film. An example of our
results comparing cDNA amplicons from RNA extracted
from RSV-infected epithelial cells daily for 4 days is shown
in Fig. 2. Differentially expressed bands are cut from the
gel, eluted and reamplified using the same primers that
generated the original signal, and northern blots gener-
ated from RNA extracted from pneumovirus-infected cells
or tissue over time and probed with the differentially
expressed amplicons serve to confirm differential expres-
sion of the identified sequence.
The DNA sequences of the newly identified differentially
expressed amplicons are compared with sequences
present in the GenBank database. Viral sequences are
expected to be upregulated over time and can be identified
immediately, because the entire genomes of both PVM and
RSV are present in GenBank. In cases in which the ampli-
con represents a newly discovered gene, potential open-
reading frames are compared with sequences that are
present in the Swiss protein database; motifs that share
homologies with known proteins represent important clues
to the identity of the differentially expressed gene.
With the help of differential display, we have identified and
characterized several genes that are upregulated in RSV-
infected respiratory epithelial cells. Two specific examples
of genes that were found to be induced during RSV infec-
tion, and later characterized as playing independent roles
in the pathophysiology of RSV infection, are the antiapop-
tosis gene IEX-1L [34] and the gene that encodes the
cytoskeletal protein cytokeratin-17 [36].
Unlike DNA viruses, which are known to encode virus-spe-
cific antiapoptosis genes, RSV – an RNA virus with a
small (approximately 15.2 kb) viral genome – was shown
to alter host cell expression of the apoptosis inhibitor IEX-
1L. After demonstrating that IEX-1L mRNA was present at
sevenfold higher concentrations in RSV-infected respira-
tory epithelial cells when compared with uninfected cells,
we concluded that this cellular response protected
against TNF-a-induced programmed cell death during viral
infection. Further efforts to determine which of the 11 RSV
proteins participate in the trans-activation of the IEX-1L
gene (either directly or indirectly) are ongoing.
A second example of a gene that is specifically upregu-
lated in RSV-infected respiratory epithelium, as identified
by differential display, is that which encodes cytoker-
atin-17 [36]. Upon characterizing the molecular events
that are important for cytokeratin-17 induction, we demon-
strated a link to an NF-kB signaling pathway. Above, we
discussed the importance of this transcription factor in the
regulation of proinflammatory cytokine gene expression,
and because of this involvement we were not surprised to
discover its role in virus-induced cytokeratin-17 gene reg-
ulation. Perhaps the most interesting observation made
during these experiments was the in situ localization of
cytokeratin-17 protein to areas of cytopathic syncytia for-
mation, suggesting a role for this cytoskeletal protein in
their formation. Of note, we observed a dramatic decrease
in RSV replication and in syncytia formation when we
blocked cytokeratin-17 expression, suggesting that block-
ing syncytia formation, at least in part, impairs the direct
cell–cell spread and productive replication of virus.
Gene arrays
Although there are several companies that market these
systems and components, the cytokine gene macroarray
systems recently developed by R&D Systems (Sigma
Genosys®; Minneapolis, MN, USA) and Clontech (Atlas®;
Palo Alto, CA, USA) represent some of the newer oppor-
tunities available that have a focus on gene products that
are known to be involved in inflammation. These arrays
consist of different cDNAs printed as PCR products onto
charged nylon membranes. An example of our experience
with the Sigma Genosys array is shown in Fig. 3. For this
example, total RNA was extracted from RSV-infected
HEp-2 cells and uninfected controls at day 3 after infec-
tion. Three micrograms of total RNA was used in a cDNA
synthesis reaction, using a proprietary mixture of 378
primer pairs and trace amounts of 32P-radiolabeled dCTP.
Respiratory Research    Vol 2 No 4 Domachowske et alThe resulting radiolabeled products were hybridized to the
macroarrays overnight at 65°C, and then washed and
exposed to film. The arrow highlights one of the most obvi-
ously upregulated sequences from this experiment, which
was identified as the gene encoding human MIP-1a. The
physiologic importance of MIP-1a upregulation during
human RSV infection and during rodent PVM bronchiolitis
has already been described.
Microarrays can be differentiated from macroarrays in
several ways. Among these differences, the microarray
matrix is a glass or plastic slide, probes are labeled with
fluorescent dye rather than via radioisotopes, and, most
significantly, microarrays generally include a larger number
and a higher density of imbedded sequences than do
macroarrays. Although this may seem to be highly appeal-
ing at first, the massive amounts of data generated by
microarray technology poses new challenges with respect
to data normalization, management, and development of
mathematical models to assist in data interpretation.
Conclusion
The pneumoviruses RSV and PVM enter respiratory
epithelial cells via a receptor-mediated event. During host-
cell attachment and internalization, the target cell begins
to alter its gene expression, which, among other events,
involves the transcriptional upregulation of cytokine and
chemokine genes. As RSV replication progresses, addi-
tional changes in cellular gene expression can be
observed, including induction of the potent antiapoptosis
gene IEX-1L and increased expression of the otherwise
quiescent gene that encodes cytokeratin-17. What we
know regarding the physiologic importance of these
genes and their gene products has been described, but
there is more to be learned. As the available technologies
evolve, we can continue to capitalize on the use of
Available online http://respiratory-research.com/content/2/4/225
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Figure 2
Display of amplicons generated from RNA extracted from RSV-infected cells at daily intervals following infection (days 0–4) using a single
anchoring primer, T11GC (downstream primer 8) and (A–H) eight random 10mers. Two differentially expressed sequences are highlighted by
arrows (the black arrow shows an upregulated amplicon, and the white arrow highlights a downregulated amplicon). Several other differentially
expressed signals are also seen.genomic approaches as large-scale screening tools to
identify genes that play important roles in the pathophysi-
ology of pneumovirus infection. These elegant and simple
tools will provide us with the means for thorough and sys-
tematic exploration of gene expression, both in the estab-
lished in vitro cell culture models and in our new murine
model of acute pneumovirus infection.
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